Clinical Trials in Detroit

Showing 7861-7880 of 19,719 trials

Pain Control After Total Knee Arthroplasty: Benefit In Adding Single Shot Adductor Canal Block to Existing Pain Regimen Protocol?

NCT02740192

This is a randomized, double blinded, standard of care controlled clinical trial. All adult patients over eighteen desiring total knee arthroplasty will be eligible. The study compares pain control, opioid consumption, and physical exam findings in patients undergoing total knee arthroplasty between patients receiving adductor canal block and those who receiving periarticular injection alone.

Pain

Henry Ford Health System128 participantsStarted Apr 2016

Detroit, Michigan, United States

COMPLETEDPhase 2< 1 mile

Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer

NCT02243358

To evaluate the safety and effectiveness of a novel neoadjuvant treatment strategy incorporating 5-fluorouracil/leucovorin with oxaliplatin ( FOLFOX )chemotherapy in combination with chemo-radiation with gemcitabine.

Pancreas Neoplasm Malignant Resectable

Henry Ford Health System24 participantsStarted Feb 2014

Detroit, Michigan, United States

COMPLETED< 1 mile

Immuno-regulatory Profiling of T Cells in GVHD Treated With Extracorporeal Photopheresis

NCT03851601

Extracorporeal Photopheresis (ECP) has been used as one of the treatments for graft versus host disease (GVHD). Responses were observed in skin, liver, GI tract, mouth, eye and lung. ECP does not cause immune suppression and therefore less risk of infection or relapse of malignancy. However, the exact mechanism of action of this expensive procedure is not fully understood and no predictors of response to ECP are known so far. This reflects the need for a better understanding of GVHD and its response to ECP. Blood samples from 15 patients who receive ECP as part of the treatment of GVHD at our institution will be collected. Samples will be analyzed using flow cytometer

GVHD

Henry Ford Health System6 participantsStarted Aug 2014

Detroit, Michigan, United States

Pain Control After Total Knee Arthroplasty: Benefit In Adding Single Shot Adductor Canal Block to Existing Pain Regimen Protocol?

Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer

Immuno-regulatory Profiling of T Cells in GVHD Treated With Extracorporeal Photopheresis

Find Trials by Condition in Detroit

Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma

The Chocolate Touch Study

A Non-interventional Study for the Collection of Biospecimens From Patients With Parkinson's Disease

Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy

A Study to Compare the Efficacy of Arfolitixorin Versus Leucovorin in Combination With 5 Fluorouracil, Oxaliplatin, and Bevacizumab in Patients With Advanced Colorectal Cancer

Human Algorithm Interactions for Acute Respiratory Failure Diagnosis

Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation

A Study of CMV Vaccine (HB-101) in Kidney Transplant Patients

A Prospective, Multicenter Study to Evaluate the ConforMIS iTotal® (CR) Knee Replacement System

Multi-Center Study to Evaluate the ConforMIS iUni Knee Implant

Antibiotic Treatment of Gulf War Veterans' Illnesses

A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults

Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study

A Prospective Study to Evaluate the ConforMIS iTotal® (PS) Knee Replacement System

A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer

COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1)

A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.